Join Us for the 7th FOP Drug Development Forum in Toronto, Canada
The FOP Drug Development Forum (DDF) is the premier biennial international scientific conference focused on advancing the development of safe and effective medications to treat and prevent life-altering signs and symptoms of fibrodysplasia ossificans progressiva (FOP).
The International FOP Association (IFOPA) is pleased to announce that the 2026 DDF will be held in Toronto, Canada, August 27-30.
The DDF is a unique opportunity to share innovative research, foster collaboration, network, and advance therapies for people living with FOP.
Registration
Due to the content being shared, the DDF is a meeting designed only for researchers, clinician scientists, pharmaceutical/biotech employees, and employees of regulatory agencies.
As previously offered, there will be a virtual attendance option for the DDF. Attending virtually allows you to watch the sessions remotely. DDF sessions are NOT posted on the IFOPA website or YouTube channel. You must be registered to watch virtually or attend the DDF in person.
Your DDF registration fee includes the August 27 Welcome Dinner plus breakfast, lunch, and a reception with hors d'oeuvres on both August 28 and 29. Breakfast on August 30 is also included, along with coffee breaks each morning and afternoon. Please note that registration rates increase on June 1.
If you are an academic researcher or clinician scientist from a low- to middle-income country, your registration fee can be reduced to $200. Please keep in mind that the IFOPA is a nonprofit organization and doesn't profit from this conference. Please only request this registration fee reduction if absolutely necessary for your participation. Please email [email protected] and include your institution and country of origin. You will receive a code to reduce your registration fee.
The IFOPA offers a $50 discount for early-career scientists defined as graduate students and those within 2 years of their terminal degree (PhD or MD). Please email [email protected] with your details, and you will receive a code to reduce your registration fee.
|
|
Early Registration Through May 31 |
Regular Registration Beginning June 1 |
|
Academic Researchers & Clinician Scientists |
$450 USD |
$550 USD |
|
Employees of Regulatory Agencies |
$650 USD |
$800 USD |
|
Biotech, Pharma & All Other Corporate Entities |
$450 USD |
$550 USD |
Call for Oral Presentations and Posters
The Call for Oral Presentations and Posters will follow the schedule listed below. Learn more and apply
|
|
|
|
|
|
|
|
|
|
Hotel Venue and Sleeping Room Rate
The DDF venue is the Sheraton Toronto Airport Hotel & Conference Centre. The special DDF sleeping room rate is 199 CAD single/double. You must reserve in the IFOPA's room block by August 3, 2026, to receive this rate. Book now
Travel and Lodging Stipends
Travel and lodging stipends provided by the IFOPA are intended to support academic researchers and clinician scientists who otherwise lack the budget to attend. Those who have never received a DDF travel stipend and are giving an oral or poster presentation will be prioritized. Apply by April 6, 2026. The following stipends are available:
- Travel stipend for an economy class ticket with reserved seating
- Lodging stipend to cover up to 3 nights of lodging (August 27, 28, 29)
The stipend application deadline is April 6, 2026. Learn more and apply
Invitation Letter for Visas
If you require an invitation letter to obtain a travel visa, please email us at [email protected].
Sponsorship and Exhibit Opportunities
Each year, we offer varying levels of sponsorship that include, among other benefits, complimentary registrations for the DDF. To receive a sponsor or exhibitor prospectus, email us at [email protected].
Questions?
You can direct any questions to [email protected]. Respondents are in the United States in the Central time zone and respond on business days, typically within 24 to 48 hours.
Prior Drug Development Forums
The FOP Drug Development Forum has been advancing FOP science and drug development at locations in North America and Europe since 2014.
 |
 |
 |
 |
 |
 |
